This handout is for hyperprolactinaemia evaluation (exclude before prolactinoma). Your care team identified this based on: incidental / screening elevated serum prolactin — finding, not diagnosis (endo soc 2011 melmed).
Other reasons your team may use this plan: woman: galactorrhoea ± oligo/amenorrhoea ± infertility (endo soc 2011 melmed); man: low libido / erectile dysfunction / gynaecomastia / infertility (pituitary soc 2023 petersenn); antipsychotic / metoclopramide / ssri / opioid / verapamil / oestrogen started — drug-induced surveillance (endo soc 2011 melmed).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| repeat resting non-stressed serum prolactin | — | — | — | Endo Soc 2011 (PMID 21296991) — a single resting non-stressed value above the reference confirms; dynamic testing is NOT recommended; repeat reclassifies stress artifact to normal |
| β-hCG / pregnancy & lactation screen | — | — | — | Endo Soc 2011 (PMID 21296991) — pregnancy/lactation is the leading physiologic cause; a positive β-hCG halts the sieve |
Plan: Hyperprolactinaemia cause-directed ladder — confirm → physiologic → drug deprescribe/swap → treat hypothyroidism → macroprolactin PEG (reassure) → hook-effect dilution → ROUTE true prolactinoma (Endo Soc 2011 Melmed; Pituitary Soc 2023 Petersenn)
Use these zones to know what to do based on how you feel.
Call 911 or go to the nearest emergency room right away if you have:
Idiopathic hyperprolactinaemia surveillance (most stable/resolve — Martin PMID 3980670); preconception counselling (prolactinoma pregnancy risk owned by endo.prolactinoma.core.v1 — micro ~1% vs macro 23% growth if DA stopped, Molitch PMID 10649822); reinforce that the antipsychotic is managed with psychiatry; return precautions (visual change, severe headache, new galactorrhoea) (Endo Soc 2011 Melmed; Pituitary Soc 2023 Petersenn)
Guideline: Endocrine Society 2011 Hyperprolactinaemia Clinical Practice Guideline (Melmed, JCEM 2011;96:273-88, PMID 21296991) + Pituitary Society 2023 international Consensus on prolactinomas (Petersenn, Nat Rev Endocrinol 2023;19:722-740, PMID 37670148); reconciled with cohort/RCT/ROC literature for the Bayesian sieve (PRL-magnitude LRs wired from Wright PMID 33966173, Leca PMID 33963239, Kyritsi PMID 29845629, Kim PMID 37057215, Kawaguchi PMID 25142896; hook effect Petakov PMID 9591215 / St-Jean PMID 8729527)